We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.02%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$694M
AUM Growth
+$90.7M
(+15%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
17.46%
Top 10 Holdings %
Top 10 Hldgs %
45.36%
Holding
89
New
20
Increased
24
Reduced
16
Closed
12
Top Buys
| 1 |
Cencora
COR
|
+$29.7M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
+$27.3M |
| 3 |
Corcept Therapeutics
CORT
|
+$25.2M |
| 4 |
Icon
ICLR
|
+$24.5M |
| 5 |
Maximus
MMS
|
+$21.8M |
Top Sells
| 1 |
Cigna
CI
|
+$47.4M |
| 2 |
Sanofi
SNY
|
+$34.1M |
| 3 |
Celcuity
CELC
|
+$30.9M |
| 4 |
Zimmer Biomet
ZBH
|
+$29.6M |
| 5 |
Kenvue
KVUE
|
+$25.3M |
Sector Composition
| 1 | Healthcare | 92.9% |
| 2 | Industrials | 7.1% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biohaven
BHVN
$2.25B
| $9.85M | 1.42% |
1,163,926
-80,838
| -6% | -$884K |
|
27
Monopar Therapeutics
MNPR
$668M
| $9.51M | 1.37% |
+173,506
| New | +$10.5M |
|
28
EyePoint Inc
EYPT
$1.15B
| $9.3M | 1.34% |
+721,785
| New | +$10.8M |
|
29
Crinetics Pharmaceuticals
CRNX
$8.86B
| $9.08M | 1.31% |
249,887
+125,046
| +100% | +$5.59M |
|
30
Edgewise Therapeutics
EWTX
$4.27B
| $8.47M | 1.22% |
268,986
+31,505
| +13% | +$909K |
|
|
CMPS
31
Compass Pathways
CMPS
$1.81B
| $8.33M | 1.2% |
+1,506,525
| New | +$10.1M |
|
32
Ocular Therapeutix
OCUL
$2.12B
| $8.2M | 1.18% |
+968,597
| New | +$9.23M |
|
33
Aquestive Therapeutics
AQST
$507M
| $7.98M | 1.15% |
1,922,887
+929,792
| +94% | +$3.77M |
|
34
Relmada Therapeutics
RLMD
$652M
| $6.72M | 0.97% |
+965,000
| New | +$4.57M |
|
|
ORKA
35
Oruka Therapeutics
ORKA
$5.28B
| $6.5M | 0.94% |
132,496
+14,370
| +12% | +$499K |
|
|
ZBIO
36
Zenas BioPharma
ZBIO
$1.82B
| $6.49M | 0.93% |
+331,730
| New | +$7.45M |
|
|
DRUG
37
Bright Minds Biosciences
DRUG
$726M
| $6.28M | 0.91% |
86,083
+4,200
| +5% | +$338K |
|
38
QuidelOrtho
QDEL
$1.2B
| $5.9M | 0.85% |
+359,011
| New | +$8.82M |
|
|
39
Zimmer Biomet
ZBH
$17.6B
| $5.66M | 0.82% |
62,613
-323,029
| -84% | -$29.6M |
|
40
Replimune Group
REPL
$829M
| $5.51M | 0.79% |
+720,036
| New | +$5.5M |
|
41
Organon & Co
OGN
$3.55B
| $5.19M | 0.75% |
865,908
-2,555,857
| -75% | -$19.2M |
|
|
OKUR
42
OnKure Therapeutics
OKUR
$170M
| $4.47M | 0.64% |
+1,078,965
| New | +$3.33M |
|
43
Disc Medicine
IRON
$2.87B
| $4.17M | 0.6% |
65,203
+7,617
| +13% | +$529K |
|
44
PMV Pharmaceuticals
PMVP
$75.7M
| $3.81M | 0.55% |
3,076,580
+440,032
| +17% | +$560K |
|
45
Immunome
IMNM
$2.56B
| $3.61M | 0.52% |
+165,110
| New | +$3.67M |
|
46
Integra LifeSciences
IART
$1.43B
| $3.61M | 0.52% |
+383,140
| New | +$4.21M |
|
47
Savara
SVRA
$1.17B
| $3.35M | 0.48% |
613,888
| – | – |
|
48
ProQR Therapeutics
PRQR
$240M
| $3.17M | 0.46% |
1,954,715
-209,466
| -10% | -$343K |
|
|
SI
49
Shoulder Innovations Inc
SI
$448M
| $3.06M | 0.44% |
210,641
-17,330
| -8% | -$241K |
|
50
Ovid Therapeutics
OVID
$459M
| $2.78M | 0.4% |
1,252,381
-175,114
| -12% | -$313K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA